Robert Herbst
Chief Tech/Sci/R&D Officer at IMMUNOGEN, INC.
Robert Herbst active positions
Companies | Position | Start | End |
---|---|---|---|
IMMUNOGEN, INC. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Robert Herbst
Training of Robert Herbst
University of Massachusetts | Doctorate Degree |
Statistics
International
United States | 3 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Robert Herbst
- Experience